Skip to main content
ESTA logo

Establishment Labs Holdings Inc.

ESTANASDAQHealthcareMedical Devices

$65.78Today:- (-)1Y +28.09%

As of Oct 26, 2026 close

Market cap
$1.98B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$47.00$97.59
Volume (live)
-
Avg. volume (3M)
387.86K

Establishment Labs Holdings (ESTA) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), Establishment Labs Holdings used $50.89M of cash in operating activities and spent $6.72M on capital expenditures. That left free cash flow of −$57.61M.

Establishment Labs Holdings Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Establishment Labs Holdings Inc. (ESTA) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Operating Activities
Net Income-51.06-84.60-78.50-75.21-41.14-38.12-38.15-21.10-34.90
Depreciation & Amortization-9.567.584.884.344.123.713.292.811.94
Deferred Income Tax6.96-2.18-3.710.090.012.480.00-13.944.96
Stock Based Compensation-11.4215.3714.8613.3610.415.726.537.323.30
Change in Working Capital-13.17-15.50-34.13-21.54-6.4412.31-4.60-14.02-14.33
Change in Accounts Receivable-11.47-26.28-11.56-12.33-6.703.81-5.51-4.67-6.91
Change in Inventory-7.06-0.47-42.23-10.90-7.644.79-3.37-6.98-6.44
Change in Accounts Payable-2.306.6718.964.384.96-0.911.83-3.91-0.88
Change in Other Working Capital7.650.182.36-2.692.944.632.451.54-0.10
Other Operating Activities27.3718.634.3826.805.511.392.955.047.05
Net Cash from Operating Activities-50.89-58.52-88.51-52.17-27.53-12.51-29.98-33.89-31.97
Investing Activities
Capital Expenditures-6.72-8.53-23.22-34.27-6.73-3.91-7.00-1.77-0.94
Acquisitions-0.31-0.050.000.000.000.000.000.000.00
Sales/Maturities of Investments0.00-7.03-1.330.000.000.000.000.000.10
Other Investing Activities-0.67-9.45-16.64-0.53-0.43-1.65-1.48-3.960.10
Net Cash from Investing Activities-7.03-15.61-24.55-34.79-7.16-5.56-7.77-5.73-0.85
Financing Activities
Debt Repayment33.4824.470.0096.39-0.18-0.2824.51-0.3122.97
Common Stock Issued7.59101.9486.713.874.5863.860.0087.6327.84
Common Stock Repurchased0.00-0.51-0.480.000.000.000.000.00-4.51
Other Financing Activities-0.64-0.511.690.00-0.361.09-1.7281.84-3.31
Net Cash from Financing Activities40.43125.9086.23100.264.0564.6722.7981.5342.99
Summary
Effect of Forex Changes on Cash2.71-1.460.51-0.36-0.470.27-0.02-0.140.21
Net Change in Cash-14.7850.31-26.3212.94-31.1146.87-14.9841.7810.39
Cash at Beginning of Period90.3540.0466.3653.4284.5237.6652.6410.860.48
Cash at End of Period75.5790.3540.0466.3653.4284.5237.6652.6410.86
Free Cash Flow-57.61-67.04-111.73-86.43-34.26-16.42-36.98-35.66-32.91
Supplemental Disclosures
Interest Paid-9.815.695.366.936.96---
Income Taxes Paid-1.742.172.130.650.32---

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Establishment Labs Holdings Cash Flow

What is Establishment Labs Holdings's free cash flow?

Establishment Labs Holdings had negative free cash flow of $57.61M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of −$50.89M minus $6.72M of capital expenditures.

How much does Establishment Labs Holdings spend on capital expenditures?

Establishment Labs Holdings spent $6.72M on capital expenditures in fiscal 2025, compared with $8.53M a year earlier.

Does Establishment Labs Holdings pay dividends or buy back shares?

Establishment Labs Holdings's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition